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A B S T R A C T
A cross-sectional population-based survey, the National FINRISK 2012 Study, designed to monitor chronic
diseases and their risk factors in Finland. A random sample of 10,000 adults aged 25–74 years, and of them,
64% (n=6424) participated the study. Participants subjectively reported the total durations for sleep and naps
(n=6238), sleep quality (n=5878), bedtimes and wake-up times separately for working days and weekends
yielding the amount of sleep debt (n=5878), and the seasonal variation in sleep duration (n=4852). The
participants were asked whether they were diagnosed or treated for common chronic diseases in the past 12
months. Logistic regression models were adopted to analysis and adjusted for a range of covariates as potential
confounding factors. Total sleep duration and nap duration prolonged in depression and other mental disorder
(p < .001 for all). Seasonal variation in sleep duration was associated with depression (p=.014), hypertension
(p=.018) and angina pectoris (p=.024). Participants with gallstones, cardiac insuﬃciency, depression, or
degenerative arthritis had poor sleep quality (odds ratios of 1.6–6.3, p=.001 or less for each). Those with
degenerative arthritis had sleep debt less (p < .05) and those with angina pectoris more (p < .05) than
individuals without these medical conditions. Depression is signiﬁcantly associated with sleep problems, albeit
no sleep debt. Cardiovascular diseases, degenerative arthritis, and gallstones had signiﬁcant associations with
one or more sleep problems. There is therefore a need for more successful management of sleep problems in
chronic diseases to improve the quality of life, to reduce treatment relapses, and to increase health and longevity
in a population.
1. Introduction
It is estimated that as high as a third of the general population
suﬀers from sleep-related problems [1]. For example in Finland,
around 10–14% of the adult population has reportedly suﬀered from
insomnia-related symptoms [2] and 9% of daytime sleepiness [3].
Studies suggest that sleep-related problems are associated with lifestyle
and socio-demographic factors such as smoking, exercise, gender, age,
and education [2,4–7]. Besides, earlier studies also suggest that sleep-
related problems and chronic non-communicable diseases have a
bidirectional relationship: it can exacerbate chronic conditions, disrupt
treatment, and increases social disability and vice versa [8–10].
Speciﬁcally, poor sleep prospectively associates with all-cause of
mortality and morbidity, for example, by increasing inﬂammation,
stress, blood pressure, impaired blood glucose control, and breathing
problems [11–13]. Further, sleep-related problems decrease the qual-
ity of life and productivity and diminish the coping capacity for
chronically ill patients, which in turn accelerate the disease's progres-
sion [14,15]. According to a most recent study, patients who have
asthma, chronic lung disease, diabetes, and strokes reported signiﬁ-
cantly higher sleep problems [16]. Several other studies suggest that
common pathophysiological mechanisms co-occur in sleep-related
problems and chronic diseases [12,17]. However, it is not yet clear if
the treatment of patients' sleep-related problems could result in
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signiﬁcant clinical improvement and reduced mortality [15].
Nevertheless, understanding this relationship could give a new per-
spective on the course, outcomes, and treatment options. Therefore, in
this study, we have examined the associations of sleep-related pro-
blems and some of the most common chronic non-communicable
diseases and medical conditions in Finland.
2. Participants and methods
The National FINRISK Study is a large cross-sectional population-
based survey on risk factors for chronic diseases. The surveys were
conducted at ﬁve-year intervals since 1972 by using independent,
random, and representative population samples. In 2012, ten thousand
randomly chosen inhabitants, aged between 25 and 74 years old, were
invited to participate in the survey. Based on the information provided
by the Finnish Population Information System, the target survey
sample was stratiﬁed, with strata of 2000 for ﬁve geographical areas
each, according to the gender and 10-year age groups. Altogether 64%
(n=6424) of those invited, participated the survey. The participants
were asked to ﬁll in the study questionnaires, which they had received
beforehand by mail, and to participate in a health examination
organized in a local health care center.
3. Sleep parameters
Information on the following sleep-related parameters was avail-
able: the total durations of sleep (in hours and minutes) and naps (in
hours and minutes) from 6242 participants, the bedtimes (as clock
time) and the wake-up times (as clock time) separately for weekdays
and weekends, sleep debt (the sum of the diﬀerences in bedtimes and
wake-up times during weekdays and weekends), and sleep quality as
“Yes” or “No” to the question “Do you think you sleep enough?” from
5878 participants, the seasonal variations in sleep duration as scored
on a Likert scale of 0 (no variation), 1 (slight variation), 2 (moderate
variation) or 3 (marked variation) from 4852 participants.
4. Covariates
The National FINRISK 2012 study survey included a self-adminis-
tered set of questionnaires with questions on socioeconomic factors,
medical history, health behavior, and psychosocial factors, physical
examination of health status, and laboratory measures for further
analyses.
Socioeconomic covariates were age and body-mass index (BMI) as
continuous variable, gender as male or female, marital status as living
with somebody (either married, cohabitating or registered partnership)
or alone (either single, separated or divorced, or widowed), education
as low (less than four years of high school), medium (either high school
only or 1–3 years post high school) or high level (4 or more years post
high school), region as living in North Karelia & Kuopio, North Savo,
Turku & Loimaa, Helsinki & Vantaa, or Oulu.
Lifestyle covariates were smoking as smokers (smoked daily or
occasionally) and non-smokers (not at all), alcohol consumption as
alcohol consumption (at least once or more than once a month) or no
alcohol consumption (no alcohol consumption at all) and exercise as
regular exercise (exercise several times a week or at least 3–4 h per
week) or no-exercise (exercise less than 3 h per week).
Common chronic non-communicable diseases and medical condi-
tions were assessed by responses to the question “Has a medical doctor
diagnosed or treated you for any of the following diseases during the
past year (last 12 months)?: Cardiovascular diseases (CVDs) symptoms
including hypertension (increased blood pressure), high cholesterol,
cardiac insuﬃciency, eﬀort angina (angina pectoris), diabetes, cancer,
bronchial asthma, chronic obstructive pulmonary disorders (COPD),
gallstone (gallbladder inﬂammation), rheumatoid arthritis, other dis-
ease of the joints, degenerative arthritis of the back (other illness of the
back), depression, other psychological illnesses, renal failure, and
proteinuria”. Responses were dichotomized into “Yes” and “No,” and
this information was available from all the participants.
5. Statistical analyses
Logistic regression models with non-communicable chronic dis-
eases and medical conditions as dependent and the sleep parameters as
independent explanatory variables (total sleep and nap durations, sleep
quality, bedtimes and wake-up times during weekdays and weekends,
sleep debt, and the seasonal variation in sleep duration) were analyzed
separately to calculate the odds ratio (OR) after controlling for the
covariates (age, gender, education, marital status, region, alcohol
consumption, smoking, physical activity, and BMI). Participants with
good sleep quality and those with no seasonal variations in sleep
duration were used as the reference categories in the analysis. The data
were analyzed with IBM SPSS Statistics 21 software.
6. Ethics
The data collection was collected according to the guidelines of the
Declaration of Helsinki and international ethical standards. The Ethics
Committee of the Hospital District of Helsinki and Uusimaa evaluated
and approved the research protocols. The ethical steering committee
within National Institute for Health and Welfare gave permission for
the sub-study and provided the data. All the participants gave a written
informed consent either in Finnish or Swedish language.
7. Results
A total of 6424 participants completed the survey. The descriptive
data on the background variables for the participants (3383 women
and 3041 men) are given in Table 1, and those of their sleep in Table 2.
The timing of sleep was reported for weekdays and weekends
separately for each chronic disease or medical condition (see supple-
mentary tables 1–2). Concerning bedtimes, those with depression or
other mental disorders had later bedtimes on weekdays and weekends
when compared to those without disorders. Later bedtimes on week-
days were present also in those with cancer, COPD or gallstones, as
compared with those not having these conditions. For the remaining,
those having a medical condition had earlier bedtimes than those not
having the medical condition in question. Concerning the wake-up
time, those with depression or other mental disorder, bronchial
asthma, or gallstones had a later wake-up time on weekdays as well
as in weekend, as compared with those not having these conditions.
Those having rheumatoid or degenerative arthritis had an earlier wake-
up time both on weekdays and in weekend than those not having these
conditions. For the remaining, those with a medical condition had a
later wake-up time on weekdays but an earlier wake-up time in
weekend, as compared with those not having the medical condition
in question.
In the present study, total sleep duration was prolonged in most of
the medical conditions and diseases assessed, signiﬁcantly in depres-
sion (p < .001) and other mental health disorder (p < .001). Similarly,
total naptime was prolonged in all the medical conditions and diseases,
except in gallstones and rheumatoid arthritis, and signiﬁcantly in
depression (p < .001) and other mental health disorder (p < .001).
Seasonal variation in sleep duration was signiﬁcantly associated with
angina pectoris (p=.024), depression (p=.014) and hypertension
(p=.018). All the medical conditions and diseases had the increased
odds for poor sleep quality, signiﬁcantly in gallstones (p=.001), cardiac
insuﬃciency (p=.001), depression (p < .001), and degenerative arthritis
(p < .001). Participants with degenerative arthritis had sleep debt
signiﬁcantly less and those with angina pectoris signiﬁcantly more
than individuals without these medical conditions (see Table 3).
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8. Discussion
To our knowledge, there area limited number of population studies
that has assessed the associations of sleep-related problems with
chronic medical conditions and diseases at large. A large cross-
sectional survey from China, among participants aged between 18
and 75 years old, suggested that there was an association between poor
sleep quality and short sleep duration (≤6 h) with type-2 diabetes [18].
Similarly, a more recent population survey from the UK, among
participants aged between 37 and 63 years, replicated poor sleep
duration to be high-risk characteristics of both CVD and type 2
diabetes [19]. In the present population study, not only CVDs but also
depression, degenerative arthritis, and gallstones were signiﬁcantly
associated with one or more sleep problems including sleep and nap
duration, seasonal variation in sleep duration, poor sleep quality, and
sleep debt. Angina pectoris was signiﬁcantly associated with in-
creased seasonal variation in sleep duration and sleep debt.
Degenerative arthritis was signiﬁcantly associated with poor sleep
quality and increased sleep debt. Depression was signiﬁcantly asso-
ciated with total sleep and nap duration, increased seasonal variations
in sleep duration, and increased odds for poor sleep quality.
The world health organization recognized CVDs as the leading
cause of global mortality, accounting for 46.2% (17.5 million) of deaths
caused by non-communicable diseases [20]. Inadequate sleep was
associated with increased risk of developing CVDs [21]. Usually, short
sleep duration was associated with cardiovascular disease-related
mortality and long sleep duration with non-cardiovascular related
mortality [22]. Further, short sleep duration was signiﬁcant risk factor
for hypertension [23]. Self-reported hypertension was associated with
sleep problems also in Finland [16]. In the present study, CVD risk
factors were signiﬁcantly associated with one or more sleep problems.
For example, cardiac insuﬃciency was signiﬁcantly associated with
increased odds for poor sleep quality. Hypertension was signiﬁcantly
associated with increased odds in seasonal variation in sleep duration.
Likewise, angina pectoris was associated with both seasonal variation
and sleep debt. The results are in line with the existing studies, that
reports higher morbidity, mortality and hospitalization rates for CVDs
[24,25]. According to the evidence, poor sleep quality and short
sleep duration ( < 6 h per night) were independent risk factors for type
2 diabetes [18,26,27]. Hormonal changes, due to sleep debt, contribute
to insulin resistance, which could, therefore, be a risk factor for
diabetes. In a case-control study, 34% of diabetic patients reported
sleep-related problems compared to 8% of controls [14]. Many experi-
mental studies indicated that short sleep duration ( < 7 h/night) and
poor sleep quality decreased glucose tolerance and reduced insulin
sensitivity, which showed the link between diabetes and sleep problem
[28–30]. Another study reported that circadian misalignment, which
commonly occurs as a consequence of poor sleep, disturbed glucose-
insulin metabolism and substrate-oxidation, thereby suggesting further
associations between sleep and diabetes [31]. However, in contrary to
earlier evidence, the present study showed no signiﬁcant associations
between sleep problems and diabetes. In like manner, sleep pro-
blem was also a common complaint of cancer patients [32]. As cited
in the review by Roscoe and colleagues [33], many studies have
reported a strong correlation between cancer-related fatigue and sleep
problems such as poor sleep quality, diﬃculties of falling asleep, and
poor sleep eﬃciency. Symptoms such as pain, melancholy, loss of
concentration as well as a decrease in other cognitive functions clusters
in cancer patients [34–36]. In contrary to earlier ﬁndings, the present
study showed no signiﬁcant association between sleep parameters and
cancer. On the other hand, patients with lung diseases often had poor
sleep quality due to abnormalities in breathing during sleep [37]. In a
large multi-country survey, the likelihood of sleep problem was
signiﬁcantly higher among older asthmatics (≥50years) than other
chronic diseases in Finland [16]. In the present study, the odds for poor
sleep quality were increased more than 1.5-fold among those with
respiratory disease. In 1989, Hyyppä and Kronholm [38] found an
association between somatic diseases and poor quality of sleep among
Finnish population. Likewise, acid-related gastrointestinal diseases
were important determinants of poor sleep quality among elderly
Finns [39]. In line with the available evidence, gallstones and degen-
erative arthritis in the present study were signiﬁcantly associated with
the increased odds of poor sleep quality. Furthermore, epidemiological
and clinical studies have reported a strong correlation between sleep
problems and depression [40,41]. In a large community-based popula-
tion study, short sleep duration, and increased sleep disturbances were
independently associated with increased cortisol secretion suggesting
chronic stress [42]. In line with the existing evidence, in the present
study depression was associated with range of sleep problems including
inadequate total sleep and nap duration, seasonal variations in sleep
duration, and poor sleep quality. Likewise, other mental disorders were
associated with inadequate total sleep and nap duration. To our
knowledge, no prior studies have directly assessed the associations of
renal failure and proteinuria with sleep-related problems. However,
some earlier studies have shown that sleep problems had increased the
risk of CVDs, hypertension, diabetes, and obesity, all of which were
implicated in the etiology of chronic kidney diseases [43]. More recent
studies have indicated sleep problems also among kidney patients
Table 1
Background characteristics of the participants.
Background measures Frequency (n) %
Age (n=6424), mean (s.d.)=51.06 (14.07) years
25–34 years 1044 16.3
35–44 years 1193 18.6
45–54 years 1302 20.3
55–64 years 1397 21.7
65–74 years 1488 23.2
BMI (n=5814), mean (s.d.)=27.11 (4.99)
Underweight ( < 18) 25 .4
Normal (18–24.99) 2154 37.0
Overweight (25–29.99) 2249 38.7
Obese ( > 30) 1386 23.8
Gender (n=6424)
Male 3041 47.3
Female 3383 52.7
Living statusa(n=6408)
Together 4605 71.9
Alone 1803 28.1
Education levelb(n=6310)
Low 2125 33.7
Medium 2115 33.5
High 2070 32.8
Region of residence (n=6424)
North Karelia & Kuopio 1282 20.0
North Savo 1334 20.8
Turku & Loimaa 1262 19.6
Helsinki & Vantaa 1219 19.0
Oulu 1327 20.7
Smokingc(n=6096)
Smokers 1447 43.0
Non-smokers 1921 57.0
Alcohol intaked(n=6403)
Alcohol intake 5582 87.2
No alcohol intake 821 12.8
Physical activitye(n=6383)
Regular exercise 4997 78.3
No exercise 1386 21.7
s.d.=standard deviation; BMI=body-mass index.
a together (either married, cohabitating, or registered partnership), alone (either
single, separated, divorced, or widowed).
b low (less than 4 years of high-school), medium (either only high-school or 1–3 years
post-high-school), high (4 or more years post-high-school) level.
c smokers (either smoked daily or occasionally), non-smokers (smoked not at all).
d alcohol intake (at least once or more than once a month), no alcohol intake (not at all
or quit using alcohol).
e regular exercise (at least 3–4 h per week or several times a week), no exercise (less
than 3 h per week).
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[44,45]. In line with the existing evidence, the present study too
showed that all of the sleep problems increased the odds of renal
failure.
Often, many risk factors attributing in the etiology of chronic
diseases are preventable. Sleep health is one such aspect of diseases
prevention. There were multiple evidences that mortality and diseases
risk factors were associated with sleep problems. Especially, long and
short duration sleep was associated with disease and mortality, most
commonly in cardiovascular diseases, hypertension, hormones and
endocrine functions [21,46,47]. Sleep duration of 7–8 h reduced the
Table 2
Descriptive data on sleep parameters by the background characteristics.
Sleep parameters
Sleep duration, hours Sleep+nap, hours Sleep debt, hours Seasonal variation in sleep duration Sleep quality
M n s.d. % M n s.d. % M n s.d. % No % Yes % Poor % Good %
Age, years
25–34 7.60 1029 1.00 16.50 7.78 982 1.32 16.70 −3.21 1003 2.46 17.60 180 3.70 498 10.30 193 3.30 776 13.20
35–44 7.53 1169 1.03 18.70 7.72 1123 1.43 19.10 −2.78 1143 1.99 20.10 197 4.10 624 12.90 194 3.30 900 15.30
45–54 7.40 1274 1.07 20.40 7.63 1224 1.41 20.80 −2.61 1216 2.00 21.40 221 4.60 766 15.80 185 3.10 1017 17.30
55–64 7.36 1352 1.18 21.70 7.68 1242 1.45 21.10 −1.96 1215 1.80 21.30 305 6.30 805 16.60 177 3.00 1095 18.60
65–74 7.54 1414 1.15 22.70 7.95 1307 1.51 22.20 −.63 1117 .96 19.60 413 8.50 843 17.40 90 1.50 1252 21.30
Total 7.48 6238 1.10 100 7.76 5878 1.43 100 −2.22 5694 2.09 100 1316 27.10 3536 72.90 839 14.30 5040 85.70
Body-mass index
< 18 7.11 25 1.36 .40 7.52 24 1.22 .50 −2.31 24 2.16 .50 5 .10 16 .30 8 .20 15 .30
18–24.99 7.55 2104 1.07 37.20 7.75 2000 1.32 37.50 −2.45 1966 1.98 38.10 455 9.40 1345 27.80 328 6.20 1653 31.10
25–29.99 7.44 2192 1.06 38.80 7.66 2067 1.44 38.80 −2.07 1980 2.13 38.40 539 11.10 1329 27.40 270 5.10 1800 33.90
> 30 7.44 1328 1.14 23.50 7.90 1242 1.52 23.30 −2.05 1192 2.00 23.10 315 6.50 838 17.30 156 2.90 1084 20.40
Total 7.48 5649 1.09 100 7.75 5333 1.42 100 −2.21 5162 2.05 100 1314 27.10 3528 72.90 762 14.30 4552 85.70
Gender
Male 7.37 2957 1.10 47.40 7.71 2809 1.44 47.80 −2.16 2652 2.10 46.60 717 14.80 1485 30.60 351 6.00 2416 41.10
Female 7.58 3281 1.08 52.60 7.80 3069 1.43 52.20 −2.28 3042 2.08 53.40 599 12.30 2051 42.30 488 8.30 2624 44.60
Total 7.48 6238 1.10 100 7.76 5878 1.43 100 −2.22 5694 2.09 100 1316 27.10 3536 72.90 839 14.30 5040 85.70
Living statusa
Together 7.51 4492 1.05 72.20 7.77 4260 1.36 72.60 −2.19 4148 1.90 73.00 985 20.30 2565 52.90 586 10.00 3675 62.60
Alone 7.40 1733 1.21 27.80 7.73 1610 1.61 27.40 −2.30 1536 2.52 27.00 329 6.80 966 19.90 251 4.30 1356 23.10
Total 7.48 6225 1.10 100 7.76 5870 1.43 100 −2.22 5684 2.09 100 1314 27.10 3531 72.90 837 14.30 5031 85.70
Education levelb
Low 7.41 2039 1.16 33.20 7.71 1879 1.59 32.40 −2.24 1789 2.38 31.80 457 9.60 1131 23.70 269 4.60 1627 28.10
Medium 7.48 2025 1.10 33.00 7.76 1925 1.43 33.20 −2.23 1850 2.09 32.90 413 8.60 1163 24.30 265 4.60 1658 28.70
High 7.55 2079 1.01 33.80 7.80 1999 1.25 34.40 −2.19 1985 1.79 35.30 421 8.80 1197 25.00 292 5.00 1674 28.90
Total 7.48 6143 1.09 100 7.76 5803 1.43 100 −2.22 5624 2.09 100 1291 27.00 3491 73.00 826 14.30 4959 85.70
Region of residence
North
Karelia
&
Kuopio
7.50 1270 1.16 20.40 7.67 1243 1.70 21.10 −2.08 1088 2.06 19.10 248 5.10 798 16.40 150 2.60 1038 17.70
North
Savo
7.52 1299 1.06 20.80 7.82 1260 1.32 21.40 −2.08 1244 1.96 21.80 262 5.40 736 15.20 151 2.60 1076 18.30
Turku &
Loimaa
7.45 1221 1.11 19.60 7.74 1128 1.35 19.20 −2.35 1128 2.14 19.80 259 5.30 668 13.80 189 3.20 956 16.30
Helsinki
& Vantaa
7.45 1179 1.10 18.90 7.73 1087 1.31 18.50 −2.43 1089 2.22 19.10 279 5.80 592 12.20 190 3.20 915 15.60
Oulu 7.49 1269 1.06 20.30 7.82 1160 1.43 19.70 −2.19 1145 2.04 20.10 268 5.50 742 15.30 159 2.70 1055 17.90
Total 7.48 6238 1.10 100 7.76 5878 1.43 100 −2.22 5694 2.09 100 1316 27.10 3536 72.90 839 14.30 5040 85.70
Smokingc
Smokers 7.37 1405 1.17 43.00 7.76 1322 1.37 42.90 −2.58 1265 2.68 42.60 252 10.20 706 28.60 193 6.30 1111 36.10
Non-
smokers
7.45 1865 1.08 57.00 7.73 1757 1.48 57.10 −2.21 1704 1.90 57.40 414 16.80 1094 44.40 247 8.00 1524 49.60
Total 7.41 3270 1.12 100 7.74 3079 1.43 100 −2.37 2969 2.27 100 666 27.00 1800 73.00 440 14.30 2635 85.70
Alcohol intaked
Alcohol
intake
7.48 5440 1.08 87.40 7.73 5141 1.39 87.60 −2.31 5017 2.09 88.30 1129 23.30 3109 64.20 745 12.70 4395 74.90
No
alcohol
intake
7.51 784 1.21 12.60 7.90 726 1.72 12.40 −1.57 667 1.99 11.70 186 3.80 419 8.70 93 1.60 631 10.80
Total 7.48 6224 1.10 100 7.75 5867 1.43 100 −2.22 5684 2.09 100 1315 27.20 3528 72.80 838 14.30 5026 85.70
Physical activitye
Regular
exercise
7.51 4877 1.04 78.50 7.75 4615 1.38 78.80 −2.18 4476 2.06 78.80 1008 20.80 2877 59.40 590 10.10 4041 69.10
No
exercise
7.39 1333 1.28 21.50 7.77 1243 1.63 21.20 −2.38 1202 2.20 21.20 305 6.30 651 13.40 244 4.20 977 16.70
Total 7.48 6210 1.10 100 7.75 5858 1.43 100 −2.22 5678 2.09 100 1313 27.10 3528 72.90 834 14.30 5018 85.70
M=mean value; s.d.=standard deviation.
a together (either married, cohabitating, or registered partnership), alone (either single, separated, divorced, or widowed).
b low (less than 4 years of high-school), medium (either only high-school or 1–3 years post-high-school), high (4 or more years post-high-school) level.
c smokers (either smoked daily or occasionally), non-smokers (smoked not at all).
d alcohol intake (at least once or more than once a month), no alcohol intake (not at all or quit using alcohol).
e regular exercise (at least 3–4 h per week or several times a week), no exercise (less than 3 h per week).
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relative risk for all-cause mortality by double compared to shorter and
longer durations [48]. For sleep debt duration, Lohr and Gingery
reported that even a 30-min diﬀerence in sleep duration on weekdays
could adversely impact health and cause diseases as compared to
weekends [49]. Next, cardiovascular and metabolic changes were
common in sleep-related problems causing chronic diseases thus
degrading sleep quality [50]. Further, there is emerging evidence that
inconsistent sleep duration and poor sleep eﬃciency were related to
adiposity, which is comorbidity in chronic diseases [51,52].
9. Limitations and strengths
There are several limitations to our study. First, sleep-related
problems were subjectively measured; therefore, some misclassiﬁca-
tions might have occurred. Nonetheless, questions about self-reported
sleep problems for timing and duration have demonstrated good
validity compared with quantitative sleep assessments [53]. Second,
the study design was cross-sectional and therefore the causation
between sleep-related problems and chronic diseases cannot be
inferred with the signiﬁcant associations observed in the results.
Further, long-term monitoring of sleep is required to detect changes
in sleep over time; hence the results are to be cautiously interpreted.
Lastly, the novel ﬁndings of the present study should be cautiously
interpreted due to a small number of cases in some of the disease
groups.
Despite several limitations of this study, there are also several
strengths. First, the results are fairly generalizable and the potential
risk of selection bias is reduced, since the dataset was based on a large
population who were randomly selected from a national registry.
Second, the study has a reliable study design as it is conducted at
every ﬁve-year interval in Finland. Third, the diseases reported in this
study were not only based on the subjective responses of the partici-
pants but were also clinically veriﬁed by following up the medication
participants used as well as with previous diagnoses assessed by a
medical doctor.
However, a longitudinal investigation is warranted to better under-
stand the associations of sleep problems and chronic diseases. Current
understanding of possible association suggests that interventions
targeting sleep problems in chronic diseases could provide promising
potential treatments. Given the emerging results suggesting many sleep
problems in some of the most common chronic diseases, it should
follow the targeted treatment of sleep problems that may positively
aﬀect diseases treatment.
Table 3
Diagnosed or treated chronic diseases or medical conditions as explained by the sleep parameters.
Chronic diseases andmedical conditionsa Prevalence, n (%) Sleep parameters
Sleep duration Nap duration Seasonal variationin sleep
durationb
Poor sleep qualityc Sleep debt
No Yes n=6238 n=6238 n=5879 n=5878 n=5694
B (SE) p B (SE) p OR (95% CI) p OR (95% CI) p B (SE) p
Hypertension 4701
(74.2)
1634
(25.8)
1.067 (.044) 1.007 (.036) 1.328 (1.05–1.68)** 1.182 (.87–1.59) 1.032 (.025)
High cholesterol 5019
(79.3)
1307
(20.7)
.978 (.044) 1.044 (.036) 1.013 (.80–1.27) 1.196 (.88–1.61) 1.031 (.026)
Cardiac insuﬃciency 6151
(97.1)
186 (2.9) .948 (.094) 1.088 (.081) 1.064 (.64–1.76) 2.725 (1.51–
4.91)***
.962 (.070)
Angina pectoris 6137
(96.8)
203 (3.2) .900 (.090) 1.030 (.076) 1.960 (1.09–3.52)* 1.552 (.79–3.01) 1.110 (.049)*
Diabetes 5877
(92.7)
462 (7.3) 1.079 (.067) 1.092 (.057) .993 (.70–1.40) 1.364 (.84–2.19) 1.059 (.043)
Cancer 6202
(97.8)
142 (2.2) 1.055 (.117) 1.193 (.103) 1.158 (.62–2.15) 1.869 (.87–3.97) .899 (.087)
Bronchial asthma 5854
(92.4)
480 (7.6) 1.028 (.064) 1.074 (.054) 1.158 (.80–1.66) 1.435 (.96–2.14) 1.000 (.035)
Chronic obstructivepulmonary disease 6266
(98.8)
73 (1.2) 1.177 (.122) 1.128 (.105) .917 (.48–1.74) 1.502 (.58–2.84) .963 (.111)
Gallstones 6278
(99.0)
64 (1.0) .789 (.173) .912 (.145) 1.144 (.35–3.67) 6.259 (2.22–
17.58)***
.863 (.122)
Rheumatoid arthritis 6201
(97.9)
134 (2.1) 1.042 (.113) .984 (.097) 1.207 (.62–2.32) 1.266 (.57–2.77) 1.020 (.069)
Other joint disease 5440
(86.0)
883 (14.0) 1.011 (.051) 1.023 (.042) 1.302 (.97–1.73) 1.334 (.93–1.90) .979 (.032)
Degenerative arthritis 5149
(81.4)
1178
(18.6)
.946 (.043) 1.002 (.035) 1.223 (.96–1.55) 1.639 (1.24–
2.15)****
.931 (.027)**
Depression 5827
(92.0)
507 (8.0) 1.291 (.060)**** 1.281 (.053)**** 1.622 (1.10–2.38)** 1.899 (1.34–
2.68)****
1.048 (.029)
Other mental disorder 6174
(97.4)
164 (2.6) 1.605 (.093)**** 1.460 (.081)**** .956 (.54–1.68) 1.342 (.77–2.32) 1.047 (.041)
Renal failure 6299
(99.4)
40 (.6) 1.045 (.205) 1.270 (.191) 2.615 (.56–12.16) 1.866 (.48–7.13) 1.065 (.063)
Proteinuria 6247
(98.8)
76 (1.2) .911 (.166) 1.014 (.010) 3.959 (.91–17.19) 1.412 (.51–3.85) 1.060 (.086)
Covariates in the models included age, gender, living status, education, region, smoking, alcohol intake, physical activity, and body-mass index. Reference group:
a no medical condition.
b no seasonal variation in sleep duration.
c good sleep quality.
* p= < .05.
** p= < .01.
*** p= < .001.
**** p= < .0001.
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10. Conclusion
According to the study results sleep problems is prevalent and
distressing in chronic diseases. It indicates a possibility of alteration in
circadian rhythms disruptions in chronic diseases that signiﬁcantly
impairs the quality of life leading to further progression of diseases.
Therefore, to improve the quality of life and to reduce treatment
relapses, there is a need for more successful management of sleep
health in chronic diseases. This could plausibly enable good sleep
health and increase longevity in the population.
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